Trials / Active Not Recruiting
Active Not RecruitingNCT05718700
Study of Bulevirtide in Participants With Chronic Hepatitis D Infection
A Registry Study of Treatment With Bulevirtide in Participants With Chronic Hepatitis D Infection
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 170 (actual)
- Sponsor
- Gilead Sciences · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main goal of this study is to collect post marketing data from patients with chronic hepatitis D virus (HDV) infection who are treated with bulevirtide to describe the long-term effects of bulevirtide treatment and evaluate the safety of participants treated with bulevirtide.
Detailed description
The study design time perspective is retrospective and prospective for participants who previously participated in MYR-Reg-02 and are currently receiving BLV and prospective for participants who are scheduled to receive BLV.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bulevirtide | Administered via subcutaneous (SC) injections |
Timeline
- Start date
- 2023-02-07
- Primary completion
- 2028-07-01
- Completion
- 2028-07-01
- First posted
- 2023-02-08
- Last updated
- 2025-11-17
Locations
53 sites across 6 countries: Austria, France, Germany, Romania, Spain, United Kingdom
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05718700. Inclusion in this directory is not an endorsement.